SILICON LABORATORIES INC. 10-Q

Item 5. Other Information ​ Not applicable ​ 43 Table of Contents Item 6. Exhibits ​ The following exhibits are filed as part of this report: ​ ​ Exhibit Number ​ 2.1* ​ Asset Purchase Agreement dated April 22, 2021 between Silicon Laboratories Inc. and Skyworks Solutions, Inc. (filed as Exhibit 2.1 to the Form 8-K filed on April 22, 2021). ​ ​ ​ 3.1* ​ Form of Fourth Amended and Restated Certificate of Incorporation of Silicon Laboratories Inc. (filed as Exhibit 3.1 to the Registration Statement on Form S-1 (Securities and Exchange Commission File No. 333-94853) (the “IPO Registration Statement”)). ​ ​ ​ 3.2* ​ Fifth Amended and Restated Bylaws of Silicon Laboratories Inc. (filed as Exhibit 3.1 to the Form 8-K filed on February 3, 2021). ​ ​ ​ 4.1* ​ Specimen certificate for shares of common stock (filed as Exhibit 4.1 to the IPO Registration Statement). ​ ​ ​ 4.2* ​ Indenture between Silicon Laboratories Inc. and Wilmington Trust, National Association, as trustee, dated March 6, 2017 (filed as Exhibit 4.1 to the Form 8-K filed on March 6, 2017). ​ ​ ​ 4.3* ​ Form of 1.375% Convertible Senior Note due 2022 (filed as Exhibit 4.2 to the Form 8-K filed on March 6, 2017). ​ ​ ​ 4.4* ​ Indenture between Silicon Laboratories Inc. and Wilmington Trust, National Association, as trustee, dated June 1, 2020 (filed as Exhibit 4.1 to the Form 8-K filed on June 1, 2020). ​ ​ ​ 4.5* ​ Form of 0.625% Convertible Senior Note due 2025 (filed as Exhibit 4.2 to the Form 8-K filed on June 1, 2020). ​ ​ ​ 4.6* ​ First Supplemental Indenture between Silicon Laboratories Inc. and Wilmington Trust, National Association, as trustee, dated January 2, 2022 (filed as Exhibit 4.1 to the Form 8-K filed on January 3, 2022). ​ ​ ​ 31.1 ​ Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002. ​ ​ ​ 31.2 ​ Certification of the Principal Financial Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002. ​ ​ ​ 32.1 ​ Certification as required by Section 906 of the Sarbanes-Oxley Act of 2002. ​ ​ ​ 101.INS ​ Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document ​ ​ ​ 101.SCH ​ Inline XBRL Taxonomy Extension Schema Document ​ ​ ​ 101.CAL ​ Inline XBRL Taxonomy Extension Calculation Linkbase Document ​ ​ ​ 101.LAB ​ Inline XBRL Taxonomy Extension Label Linkbase Document ​ ​ ​ 101.PRE ​ Inline XBRL Taxonomy Extension Presentation Linkbase Document ​ ​ ​ 101.DEF ​ Inline XBRL Taxonomy Extension Definition Linkbase Document ​ ​ ​ 104 ​ Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) * Incorporated herein by reference to the indicated filing. ​ ​ 44 Table of Contents SIGNATURES ​ Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ​ ​ SILICON LABORATORIES INC. ​ ​ ​ ​ ​ ​ July 27, 2022 ​ /s/ R. Matthew Johnson ​ ​ ​ ​ ​ ​ Date ​ R. Matthew Johnson ​ ​ President and ​ ​ Chief Executive Officer ​ ​ (Principal Executive Officer) ​ ​ ​ ​ ​ ​ July 27, 2022 ​ /s/ John C. Hollister ​ ​ ​ ​ ​ ​ Date ​ John C. Hollister ​ ​ Senior Vice President and ​ ​ Chief Financial Officer ​ ​ (Principal Financial Officer) ​ ​ ​ ​ ​ ​ July 27, 2022 ​ /s/ Mark D. Mauldin ​ ​ ​ ​ ​ ​ Date ​ Mark D. Mauldin ​ ​ Chief Accounting Officer ​ ​ (Principal Accounting Officer) ​ ​ 45